Details for New Drug Application (NDA): 074131
✉ Email this page to a colleague
NDA 074131 describes PIROXICAM, which is a drug marketed by Breckenridge, Cycle, Egis, Flamingo Pharms, Hikma, Ivax Sub Teva Pharms, Micro Labs, Mylan, Pharmobedient, SCS, Solis Pharms, Strides Pharma, Sun Pharm Industries, Teva, Teva Pharms, Unichem, Watson Labs, and Zydus Lifesciences, and is included in twenty-two NDAs. It is available from nine suppliers. Additional details are available on the PIROXICAM profile page.
The generic ingredient in PIROXICAM is piroxicam. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the piroxicam profile page.
The generic ingredient in PIROXICAM is piroxicam. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the piroxicam profile page.
Pharmacology for NDA: 074131
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 074131
Suppliers and Packaging for NDA: 074131
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PIROXICAM | piroxicam | CAPSULE;ORAL | 074131 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-0756 | 0093-0756-01 | 100 CAPSULE in 1 BOTTLE (0093-0756-01) |
| PIROXICAM | piroxicam | CAPSULE;ORAL | 074131 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-0757 | 0093-0757-01 | 100 CAPSULE in 1 BOTTLE (0093-0757-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Dec 11, 1992 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 20MG | ||||
| Approval Date: | Dec 11, 1992 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
